Phase 2 of bamosiran (SYL040012), a novel RNAi based compound for the treatment of increased intraocular pressure associated to glaucoma

Authors
Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2014
This article has no abstract
Epistemonikos ID: a1dc0e81f9184202d7da1ee4af262bd2b1e14cac
First added on: Feb 08, 2025